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CC BY-NC-ND license (http://creativBackground: Domperidone has been widely used in children with gastroesophageal reflux dis-
ease (GERD). Studies on the effects of domperidone on corrected QT interval (QTc) in young
children are limited. Our aim was to study the effect of domperidone on the repolarization ab-
normalities assessed by electrocardiogram (ECG) in young children.
Methods: ECG was performed in children <2 years of age before and after taking domperidone
orally 0.3 mg/kg three times/day for at least a 1 week period. Each ECG was reviewed and QT,
RR, and Tpeak to Tend intervals (TpTe) were measured to calculate the QTc and TpTe/QT ratio.
Results: A total of 22 patients (12 male) with a median age of 8.5 months (1e24 months) were
enrolled. Most patients (59.1%) were under 1 year of age. Themedian baseline QTc (410millisec-
onds, 350e450 milliseconds) was not significantly different from the QTc after taking domperi-
done (410 milliseconds, 320e560 milliseconds), pZ 0.159. Only two patients showed a QTc
increase 450 milliseconds. The baseline TpTe interval and TpTe/QT (105 milliseconds, 60
e170milliseconds and 0.27milliseconds, 0.15e0.43milliseconds)were significantly greater than
the TpTe interval and TpTe/QT in children after taking domperidone (90 milliseconds, 60e140
milliseconds and 0.22 milliseconds, 0.15e0.29 milliseconds), pZ 0.001 and 0.004, respectively.
Conclusions: Our data demonstrate that domperidone treatment over a short-term period in
children <2 years of age did not lengthen QTc significantly; however, QTc increased 450 milli-
seconds in two patients with concomitant lansoprazole. Routine baseline and follow-up ECGmay
not be necessary in each individual case receiving only domperidone.
Copyrightª 2016, TaiwanPediatric Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).t of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama VI Road
d.
ol.ac.th (A. Khositseth).
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Effect of Domperidone on QT Interval 611. IntroductionTable 1 Underlying diseases and concomitant
medications.
Underlying diseases N (%) Medications N (%)
Seizure 1 (7.14) Lansoprazole 17 (62.96)
Thyroid disease 1 (7.14) Phenobarbital 2 (7.4)
Iron deficiency 2 (14.29) Vigabatrin 1 (3.7)
Chronic liver disease 1 (7.14) Nitrazepam 1 (3.7)
Heart disease 2 (14.29) Multivitamin 6 (22.22)
Cerebral palsy 7 (50.0)Domperidone is a dopamine-2 receptor antagonist1e3 and
affects the chemoreceptor trigger zone on the fourth
ventricle outside the blood brain barrier and the motor
function of the stomach and small intestine. In contrast to
metoclopramide, domperidone does not cross the blood
brain barrier; therefore, neurological side effects such as
dystonic reaction are rare. Domperidone is broadly pre-
scribed for acute vomiting, gastroparesis and gastroesoph-
ageal reflux disease (GERD), since its safety profiles are
more acceptable than metoclopramide and cisapride. The
study of domperidone treatment at the dose of 0.3 mg/kg/
dose in 13 newborns demonstrated no serious side effects.2
However, Rocha and Barbosa4 reported a QT prolongation in
a 4-month-old infant receiving a high dose of 0.6 mg/kg
three times/day. In addition, domperidone caused QT
prolongation in patients who received concomitant treat-
ment with ketoconazole.5 There were few research studies
of the side effects on electrocardiogram (ECG) in children
and the results were controversial. Djeddi et al6 reported
QT prolongation in 31 infants with gastroesophageal reflux
treated with domperidone. The study by Gu¨nlemez et al7
showed no difference of corrected QT before and after
domperidone therapy in 40 premature infants, except for
two babies who developed corrected QT interval (QTc)
prolongation. The aim of our study was to determine the
cardiac effect of short-term oral domperidone on the
repolarization abnormalities assessed by measuring QTc
and Tpeak to Tend (TpTe) interval on ECG.
2. Patients and methods
Children who were aged <2 years with suspected symptoms
of GERD and who required domperidone therapy at a single
university hospital were enrolled. Informed consent was
obtained from the parents of all patients before enrolment.
Domperidone was given at the dose of 0.3 mg/kg before
meals three times/day. A 12-lead ECG using paper speed at
25 mm/s or 50 mm/s was obtained in each child at baseline
before starting domperidone and at 1 week following
domperidone administration. All ECGs were performed
without sedation, but all children lay calmly in their
mothers’ laps or on beds in a nonagitated state.
2.1. Measurements and calculations
Each ECG was reviewed by a pediatric cardiologist (YB)
blinded to the clinical setting. The QT interval, defined as
the interval from the beginning of the Q wave to the end of
the T wave, the RR interval, defined as the interval from
the preceding R wave to the consecutive R wave, and the
TpTe interval, defined as the interval from the peak of the
T wave to the end of the T wave, were measured in lead II.
The QTc was calculated from Bazett’s formula8 as the QT
interval in seconds divided by the square root of the RR
interval in seconds. The prolonged QTc was defined as QTc
>440 milliseconds for infants <1 year of age and >450
milliseconds for children aged 1e5 years.9 The normal TpTe
interval was 62.4  11 milliseconds (39e97 milliseconds) for
children <1 year of age and 67.6  9.2 milliseconds (43e89milliseconds) for children aged 1e5 years.10 The prolonged
TpTe interval was defined as TpTe/QT > 0.21.10 QTc, TpTe
interval, and TpTe/QT were compared between, before,
and after taking domperidone. Potential factors influencing
the effects, such as age, dosage, pre-existing disease, and
concomitant medicines, were also evaluated.
2.2. Statistical analysis
Descriptive statistics were calculated and analyzed to ex-
press mean, standard deviation (SD), median, range,
maximum and minimum value, frequency, percentage, and
distribution. Multiple logistic regressions and the Mann-
Whitney test were used to find the risk factors related to an
abnormal ECG.
3. Results
Twenty-two patients (12 male, 54.6%) with symptoms sus-
pected of GERD were enrolled. The median age was 8.5
months (range 1e24 months) and median weight of 6.3 kg
(range 3.2e13.8 kg). Most patients (59.1%) were <1 year
old. Concomitant medications consisted of lansoprazole,
phenobarbital, vigabatrin, nitrazepam, and vitamins.
Seventeen patients received lansoprazole while five pa-
tients did not receive this medication. The associated dis-
eases consisted of epilepsy, heart disease, thyrotoxinemia,
iron deficiency anemia, cerebral palsy, and hepatitis
(Table 1).
The median baseline QTc before taking domperidone
was 410 milliseconds (range 350e450 milliseconds). The
median QTc after taking domperidone was 410 milliseconds
(range 320e450 milliseconds), which was not significantly
different from the baseline (p Z 0.159). At baseline, only
one patient had a QTc of 450 milliseconds. After taking
domperidone, her QTc decreased to 400 milliseconds. When
the QTc at baseline and after domperidone therapy was
compared in each individual patient, an increased from the
baseline was seen in eight patients (36%), but only two
patients showed an increase in QTc 450 milliseconds
(Figure 1). Two had a baseline QTc of 420 milliseconds and
440 milliseconds, and after domperidone their QTc
increased to 450 milliseconds (Figure 2). Subgroup analysis
demonstrated that no factors were associated with
increased QTc  450 milliseconds, including age, sex, pre-
existing disease, and concomitant medicines. Interest-
ingly, two out of 17 patients receiving lansoprazole showed
QTc 450 milliseconds after domperidone therapy. In
Figure 1 Linear graph comparing corrected QT interval (QTc)
in milliseconds before and after taking domperidone in each
patient.
62 T. Ngoenmak et alcontrast, none of the five patients without lansoprazole had
QTc 450 milliseconds after domperidone therapy.
The median baseline TpTe interval and TpTe/QT before
taking domperidone were 105 milliseconds (range 60e170
milliseconds) and 0.27 milliseconds (range 0.15e0.43Figure 2 Electrocardiogram tracing showing measurement of Tpe
with corrected QT interval (QTc) increased from 420 milliseconds to
milliseconds to 450 milliseconds.milliseconds), respectively. Interestingly, the median TpTe
interval and TpTe/QT after taking domperidone were 90
milliseconds (range 60e140 milliseconds) and 0.22 milli-
seconds (range 0.15e0.34 milliseconds), which were
significantly less than before taking domperidone,
p Z 0.001 and 0.004, respectively. The TpTe interval
(Figure 3) and TpTe/QT (Figure 4) decreased after taking
domperidone in most patients.4. Discussion
Currently, domperidone is widely prescribed for children
<2 years old with GERD. Although proton pump inhibitors
are the treatment of choice for GERD in children, proki-
netics may be of benefit to some patients who do not have
an adequate therapeutic response to proton pump in-
hibitors. When prokinetics are indicated, domperidone is
preferred, due to an awareness of the side effects of the
others. Rocha and Barbosa4 reported prolongation of the QT
interval after oral use of high-dose domperidone in a 4-
month-old infant, which was normalized after discontinu-
ation. The authors recommended obtaining 12 ECGs both
before and after taking domperidone. Djeddi et al6ak to Tend (TpTe), QT, and RR interval in lead II. (A) One patient
450 milliseconds; (B) one patient with QTc increased from 440
Figure 3 Linear graph comparing Tpeak to Tend interval
(TpTe) in milliseconds before and after taking domperidone in
each patient.
Figure 4 Linear graph comparing Tpeak to Tend interval/QT
interval ratio (TpTe/QT) before and after taking domperidone
in each patient.
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48% of 31 infants treated with domperidone. The risk fac-
tors for domperidone-induced QTc prolongation identified
in this study were advanced gestational age and hyper-
kalemia. Gu¨nlemez et al7 demonstrated that domperidone
therapy in modest doses (0.25 mg/kg four times/day) in
premature infants was safe except in two out of 40 infants
who developed QTc prolongation above 450 milliseconds
without clinical arrhythmia. The potential risk factors were
inconclusive. In our cohort study on the effect of short-
term oral domperidone, QTc after taking domperidone
was not significantly different from baseline QTc before
taking domperidone. However, eight of 22 patients (36%)
receiving domperidone had increased QTc, although the
percentage increase of QTc in most cases was small and the
QTc interval was <450 milliseconds in most patients (20/22,
91%). Only two of 22 patients (9%) had QTc 450 millisec-
onds after taking domperidone, increasing from 420 milli-
seconds and 440 milliseconds to 450 milliseconds,
respectively. Interestingly, both patients had concomitant
lansoprazole therapy. The ratio of patients developing QTc
450 milliseconds was not significantly different between
patients with and without lansoprazole therapy. This might
be due to the small number of patients withoutlansoprazole therapy. Nevertheless, these findings may also
indicate that domperidone could have some cardiac effects
in some selected patients and caution should be exercised
especially with concomitant use of lansoprazole.
The TpTe interval is an index of transmural dispersion of
repolarization and spatial dispersion of repolarization
index. Prolongation of this interval has been reported to
predispose to life-threatening ventricular arrhythmias in
long QT syndrome, polymorphic catecholaminergic ven-
tricular tachycardia, Brugada syndrome, and short QT syn-
drome, and it could be an indicator of increased risk of
sudden cardiac death.10e14 Measurement of the TpTe in-
terval in such children may be an indicator for potential
ventricular arrhythmias.15e18 The long TpTe interval has
been associated with cardiac arrhythmia.15,17 Interestingly,
the TpTe/QT ratio has been shown to be an electrocardio-
graphic index of arrhythmogenesis. There were increased
chances of cardiac arrhythmia and ventricular tachycardia
in patients with long QT syndrome, Brugada syndrome,
short QT syndrome, and in those with organic heart diseases
such as acute myocardial infarction, if their TpTe/QT
values in lead II were greater than the 98th percentile or
0.2110 despite normal QTc.16,17,19 Functional reentry is the
underlying mechanism for arrhythmogenesis associated
with an increased TpTe/QT ratio.12 The studies on TpTe
interval and TpTe/QT ratio in children taking domperidone
are very limited. Most patients had baseline TpTe interval
and TpTe/QT ratio higher than the referenced values.10
Surprisingly, our study demonstrated that TpTe interval
and TpTe/QT in lead II after taking domperidone were
significantly shorter than those of the baseline. Biega-
nowska et al20 recently reported TpTe intervals in 131
healthy children (64 girls) aged 2.3 to 18.5 years (mean 9.1
years) from all leads of ECG and found that TpTe intervals
varied significantly between individual leads, the longest
one being in lead V3, and the shortest in leads III and V1.
TpTe dispersion varied from 6 milliseconds to 80 millisec-
onds. In most leads, higher TpTe/QT ratios were seen in
boys regardless of age. The TpTe intervals lengthened with
lowering heart rate.20 It was recommended that the TpTe
interval should be measured in precordial leads.20 We
believe that the interpretation of TpTe interval and TpTe/
QT should be carefully concluded, since little information
for these parameters has been reported in the pediatric
population, especially during infancy.
Experimental study has demonstrated that domperidone
can prolong cardiac repolarization by blocking the rapid
component (Ikr) of the delayed rectifier potassium cur-
rent.21 The cardiac electrophysiological effects are similar
to those of cisapride.21 Excessive Ikr block may lead to
triggering tachyarrhythmia and sudden death.22 Pediatri-
cians should aware of potential cardiac side effects of
domperidone particularly when prescribing high doses, or
using concomitant medications known to increase QT in-
terval, and drugs that inhibit P450 enzyme, which are
important for drug clearance.225. Conclusions
In summary, domperidone treatment over a short-term
period in children <2 years of age did not significantly
64 T. Ngoenmak et allengthen QTc. Based on the results of the current study, the
routine baseline and follow-up ECG may not be generally
necessary in each individual case receiving only domper-
idone. However, further studies with larger sample sizes
are required to confirm this suggestion.Conflicts of interest
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